Stocks to buy

Sometimes the best way to jump into an industry like biotech is to follow the popular trades. Though that may go against the common advice of avoiding hype cycles and the fear of missing out, seeing which biotech stocks are experiencing the highest 24-hour trading volumes can be a quick way to learn which catalysts

Investing in biotech stocks is a thrilling ride. These innovative businesses developing breakthrough drugs can generate enormous profits for investors but also destroy significant value if their investigational therapies fail to make it to market. The pandemic focused a lot of attention on the sector. The SDPR S&P Biotech ETF (NYSEARCA:XBI) soared 49% in 2020,

There is no debating that stock market valuations are sky high right now. While the Federal Reserve hinted at rate cuts in September at its latest Federal Open Market Committee (FOMC) meeting, that doesn’t mean that stocks are setting up for new highs. Investors searching for safe stocks for a bear market should start their preparation

In the fast-paced world of investing, it’s rare to find low-cost growth stocks to buy and hold for the long term. Low-cost growth stocks are often found in sectors with high growth potential. For example, in the general tech industry or in more niche sectors like biotechnology. These stocks offer the possibility of substantial returns

One of the goals of investing should be to put your portfolio on autopilot. Fill it with quality companies and then set it and forget it. The benefit of the strategy is it removes the temptation to trade in and out of stocks. JPMorgan Asset Management found that over the 20-year period between January 2003

Chinese stocks have been depressed for an extended period and multiple factors have contributed to the price and time correction. This includes macroeconomic headwinds, regulatory headwinds, and geopolitical concerns. The result is that there are several undervalued Chinese stocks, but investors still seem to be gripped by fear. In my view, this is a golden opportunity to buy quality

We’re entering the dog days of summer, and the stock market continues to be a rollercoaster ride for investors. After a strong rally in the year’s first half, the waters got choppy in July as investors rotated capital out of technology stocks in favor of small-caps and value stocks. But then, just when it looked

An undeniable fact about equities is that it always remains in a long-term uptrend. In the last ten years, the S&P 500 Index has delivered total returns at a CAGR of 12.75%. Even if we extend the time horizon, the markets have rewarded investors. The key is good stock selection and the patience to hold.

It is no secret that the crumbling and outdated U.S. infrastructure needs an upgrade. Finally, after years of inaction, the federal government has taken measures to address this issue. With an infrastructure overhaul taking shape, construction stocks could have a decade of upside. Now that funding for infrastructure spending is in place, the sector is

For many years, the electric vehicle (EV) industry, including EV charging stocks, has been plagued by two main adoption obstacles. Those include cars looking awkward and high upfront cost. Tesla (NASDAQ:TSLA) largely changed the shift for the former. But battery costs are still exerting a heavy toll on people’s EV perception. Nonetheless, fans of quiet

Small-cap stocks are back in favor. After languishing behind their larger brethren for years, small-cap stocks are roaring ahead as investors rotate into the sector once more. The small-cap Russell 2000 index is up 10% in July versus the S&P 500’s flat performance and the tech-heavy Nasdaq 100 falling close to 5%. It was a

Stock prices follow earnings. This nugget of investing wisdom essentially says the most important thing long-term investors should focus on is the profits a company makes. Over time, a company growing its earnings will move the stock higher. Of course, it’s not a hard-and-fast rule. We’ve all seen stocks beat earnings estimates, and raise their

The REITs (Real Estate Investment Trusts) are worth checking out if you’re looking to get paid handsome distributions while you wait for the Federal Reserve to finally cut interest rates. Undoubtedly, capital-intensive REITs stand out as big winners as rates fall. And while it’s not guaranteed that rates will fall as quickly as they are

Due to milestones like NASA’s Artemis 2 Moon orbit in late 2024, space stocks remain popular. Astronauts are already preparing for this voyage toward a permanent Moon presence. The National Space Council’s new plan stresses Moon and Mars missions and ambitious human space exploration and development. Moreover, the U.S. government’s 2024 budget for NASA is

The U.S. desperately needs better infrastructure, which, if addressed soon, could create a massive boom in infrastructure stocks. Right now, we’re in bad shape.  Look at bridges, for example. According to the Infrastructure Report Card, 42% of the 617,000 bridges in the U.S. are more than 50 years old. And about 7.5% are structurally deficient,

Investors continue to seek out top financial stocks to buy, as the macroeconomic winds appear to be shifting. Federal Reserve chairman Jerome Powell all but served up a rate cut in September on a golden platter on Wednesday at the highly-anticipated Q&A session following the July interest rate session. At this press conference, the chairman

Major technology companies needed strong Q2 earnings. In the lead-up to the first prints of the mega-cap tech names, the Nasdaq Composite index tanked, declining more than 2% in a single day and worsening the rotation out of technology stocks that have been ongoing since the year’s second half began in July. The good news

Amid the choppiness on Wall Street, tech darlings are in the spotlight this earnings season. Similarly, the leading software company Adobe (NASDAQ:ADBE), known for its products like Photoshop, Illustrator and Acrobat, has also been volatile. ADBE stock reached multi-year highs of $638 in early February but its year-to-date (YTD) performance has raised eyebrows. ADBE stock

Easily one of the biggest trends right now in the field of medicine is the weight loss drug surge. Without attempting to sound cynical, the reality is that the sector enjoys a massive total addressable market. According to Axios, almost 115 million U.S. adults and children are obese. Prior efforts to address this situation have

Although acquiring nominally cheap securities doesn’t necessarily mean anything, targeting undervalued stocks is another ballgame. By undervalued, we’re talking about enterprises that should be priced higher thanks to various factors. Typically, such discounted entities are trading below what their earnings and sales performance would dictate. To be sure, there is a field of thought that